Google Scholar list

Preprints:

• Faseela EE, Notani D, Sabarinathan R. Replication stress underlies genomic instability at CTCF/cohesin-binding sites in cancer. bioRxiv, 2023. 

Selected publications:

• Singh AK, Walavalkar K,  Tavernari D, Ciriello G, Notani D, Sabarinathan R. Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers. Molecular Oncology, 2023.
• Kumar R, Dhaka B,  Sahoo S, Jolly MK, Sabarinathan R. Prognostic association of immunoproteasome expression in solid tumours is governed by the immediate immune environment. Molecular Oncology,17: 1041-1059, 2023.
• Dhaka B, Sabarinathan R. Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours. BMC Cancer, 21:669, 2021.
• Bala P, Singh AK, Kavadipula P, Kotapalli V, Sabarinathan R, Bashyam MD. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Oncogene, 40:863-874, 2021.
• The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature, 578, 82-93, 2020.
• Gonzalez-Perez A, Sabarinathan R, Lopez-Bigas N. Local Determinants of the Mutational Landscape of the Human Genome. Cell, 177:101-114, 2019. (Review article)
• Sabarinathan R,  Mularoni L, Deu-Pons J, Gonzalez-Perez A, Lopez-Bigas N. Nucleotide excision repair is impaired by binding of transcription factors to DNA. Nature, 532:264-267, 2016.
• Frigola J, Sabarinathan R,  Mularoni L, Muiños F, Gonzalez-Perez A, Lopez-Bigas N. Reduced mutation rate in exons due to differential mismatch repair. Nature Genetics, 49:1684-1692, 2017.
• Mularoni L, Sabarinathan R,  Deu-Pons J, Gonzalez-Perez A, Lopez-Bigas N.  OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations. Genome Biology, 17:128, 2016.
• Sabarinathan R, Tafer H, Seemann SE, Hofacker IL, Stadler PF, Gorodkin J. RNAsnp: efficient detection of local RNA secondary structure changes induced by SNPs. Human Mutation, 34:546-556, 2013.